SUMMARY Idiopathic polyradiculoneuropathy with primary axonal lesions is rarely encountered. Two cases are reported with a chronic relapsing course and a fatal outcome. Neuropathological examination of biopsied peripheral nerve in the two patients and in a necropsy case showed loss of myelinated fibres, but neither active demyelination nor inflammatory cells were observed. Acute and chronic relapsing axonal polyradiculoneuropathies appear to be two clinical forms of a peculiar entity different from GBS Guillain Barre syndrome (GBS) is typically characterised by an acute demyelinating polyradiculoneuropathy which progresses to maximum weakness within 2 to 3 weeks of onset and recovers in most cases after 6 to 12 months.'
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Another type of idiopathic demyelinating polyradiculoneuropathy may be observed with similar clinical, electrophysiological and pathological features, but with a protracted initial phase and a chronic monophasic or relapsing course. 2 Idiopathic polyradiculoneuropathy with primary axonal lesions is rarely encountered. Its course may be acute3 or chronic relapsing. 4 Electrophysiological and pathological signs are quite different from the demyelinating forms and prognosis is generally poor.
We report two cases with chronic relapsing polyradiculoneuropathy, where peripheral nerve biopsy and in one case necropsy disclosed primary axonal lesions.
Case reports
Case I A 54 year old woman had been suffering from progressive motor paresis for 6 myelin (fig 3) . The presence of small axonal sprouts in the same schwann cell cytoplasm indicated a regenerating process after axonal degeneration. No changes of active demyelination and no inflammatory cells were seen. Prednisone therapy (60 mg/daily) led to great improvement, and the patient was able to walk with sticks after 3 weeks and was discharged on 21 October with a reduced dose of prednisone (30 mg/daily).
Ten days later a relapse occurred resulting in a motor deficit of all limbs, and the patient became quadriplegic in a few days. Prednisone was increased to 60 mg/daily but without beneficial effect. Four 3 1 plasma exchanges given over 10 days gave a dramatic improvement. Motor strength was normal after the fourth pheresis. CSF protein at that time was 157 mg/100 ml. The patient was discharged. A third relapse occurred a month later with progressive flaccid quadriplegia and weakness of bulbar musculature. Four 3 1 plasma exchanges were given in 12 days. An improvement occurred again but less quickly than for the first cure. In the final days of December, the patient was able to walk unaided. On 9 January a fourth relapse occurred. Four .;. .i patients showed an axonal loss of the largest myelinated fibres, clusters of regenerating axons; in case 2 very few enlarged axons were stripped of myelin. In neither case were any aspects of active demyelination observed as described in typical forms of GBS."8 Chronic relapsing idiopathic polyneuropathy with primary axonal lesions These findings seem to favour an initial axonal attack, possibly caused by a deleterious humoral factor. Plasma exchanges were given 6 and 2 months respectively after onset ofthe disease. In case 1, improvement was slight and each relapse left the patient more and more disabled. In case 2 the first two relapses completely regressed in a few days, but then plasma exchanges were ineffective. Early relapses have been observed after plasma exchanges in acute polyneuropathies"' and in chronic relapsing forms.4
Outcome in polyneuropathy with axonal lesions is poor, and death occurred in our two patients. In the study of Feasby et al3 one patient died, two remained severely handicapped and only one could work again. The three patients with axonal lesions reported by Pollard et al4 exhibited severe sensory and motor deficits with wasting. In chronic relapsing axonal polyneuropathy, it is generally believed that plasma exchanges are not of value. It is possible that factors involved in axonal lesions may be less influenced by exchanges than those causing demyelination, but other factors must be considered. American'8 and French'9 cooperative groups on plasma exchange in GBS have indicated that the delay between the onset of the disease and the start of pheresis has a bearing on outcome. Moreover, it is possible that axonal lesions, once constituted, continue to evolve independently of causative factors.
Chronic relapsing polyneuropathy with primary axonal lesions may have clinical and biological features similar to the demyelinating forms: motor deficit of all limbs, areflexia, albuminocytologic dissociation in the CSF, and respiratory failure, but muscle wasting is much more pronounced in the former and outcome is worse. Neuropathologic lesions are quite different since no active demyelinating lesions have been observed in any case. However, the second case exhibited a few features of isolated remyelinating fibres, which suggests a previous demyelinating process. Acute and chronic relapsing axonal polyradiculoneuropathy appear to be two clinical forms of a distinct entity different from GBS, despite some common clinical and biological features.
The causative factors of such axonal lesions remain to be clarified.
